A biological preparation made from killed or weakened microorganisms is known as vaccine. It consists of an agent that resembles with a disease-causing microorganism. The H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease in human beings commonly referred to as swine flu. The H1N1 virus mainly affects the respiratory system, including the nose, lungs, and throat of the infected person. The virus has caused a worldwide pandemic in the recent years.
Read Report Overview -
https://www.transparencymarketresearch.com/h1n1-vaccines-market.html
The H1N1 virus can be classified on the basis of antigenicity of its surface glycoproteins hemagglutinin and neuraminidase. Hemagglutinin helps the virus bind to host cell receptors. This simplifies viral entry into the host cell. The neuraminidase protein enzymatically splits terminal sialic acid residues from mucins, thereby letting the virus reach underlying cells in the respiratory tract. H1N1 vaccines are administered for active immunization against the H1N1 influenza virus.
A major driver of the global H1N1 vaccines market is a rise in the incidence of infections across the globe. According to the World Health Organization’s 2018 factsheet estimates, 290,000 to 650,000 deaths are reported each year from all types of influenza infections (including influenza A i.e. H1N1). Worldwide, around 3 to 5 million cases of severe viral influenza infections are diagnosed each year.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=Brep_id=60471
Rise in awareness among physicians and end-users about disease preventation and government initiatives towards reforming health are likely to boost the market in the coming years. Moreover, a strong clinical pipeline of H1N1 vaccines further contributes to the growth of the market. However, a lack of awareness and stringent regulations hinder the growth of the global H1N1 vaccines market.
The global H1N1 vaccines market can be segmented based on vaccine, route of administration, distribution channel, and geography. Based on vaccine, the market can be classified into inactivated vaccine and live attenuated vaccine. In terms of route of administration, the global H1N1 vaccines market can be categorized into parentral and nasal. Based on distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.
Get COVID-19 Analysis on H1N1 Vaccines Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19rep_id=60471
Based on geography, the global H1N1 vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East Africa. North America and Europe lead the global H1N1 vaccines market in terms of revenue. This is primarily due to developed research infrastructure and increased awareness among end-users in these regions. The H1N1 vaccines market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to a rise in cases of H1N1 virus infections in the region, particularly in India and China.
Moreover, an increase in awareness among the masses about diseases and increase in government initiatives and programs to raise awareness among people about various infectious diseases in Asia Pacifc are likely to boost the market in the region. There has been a significant rise in demand for H1N1 vaccines for the prevention of swine flu. Furthermore, several companies are constructing their manufacturing and research facilities in developing regions due to availability of a large patientpool, low wages, and less stringent environment and health and safety regulations.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EBrep_id=60471
Development of medical infrastructure, growth of economies in developing countries such as India and China, discovery of new vaccines with greater efficiency, and advancements in the field of biomedical science are expected to offer attractive opportunities to players in the H1N1 vaccines market in Asia Pacific. Frequent strategic collaborations and mergers between manufacturing companies and government associations as well as product launches are the current trends in the global H1N1 vaccines market.
Some of the major players operating in the global H1N1 vaccines market are Medimmune, GlaxoSmithKline, AstraZeneca plc, Novartis, Sanofi AG. Sinovac, Baxter, Commonwealth Serum Laboratories, Zydus Cadila, and others.
More Trending Reports by Transparency Market Research –
Cancer Diagnostics Market:
Intraocular Lens Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
